Academic Journal

Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center

التفاصيل البيبلوغرافية
العنوان: Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center
المؤلفون: Pedrosa de Lira de Morais, Carla Cristina, Dias Alves Pinto, Juliana, Wagner de Souza, Karen, Izu, Marina, Fernando da Silva Bouzas, Luis, Henrique Paraguassú-Braga, Flávio
المصدر: Hematology, Transfusion and Cell Therapy. January 2022 44(1)
بيانات النشر: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), 2022.
سنة النشر: 2022
مصطلحات موضوعية: Stem cell CD34+, ISHAGE, Flow cytometry, Dual-platform, Single-platform
الوصف: Background This study aims to validate the single-platform method for enumeration of CD34+ cells, by comparing the performance of two different commercial kits, as well as to evaluate the efficiency of the AccuriTM C6 cytometer in providing direct counts of absolute cell numbers. Method We evaluated 20 samples from umbilical cord blood (UCB), comparing the two different methodologies for enumeration of CD34+ cells: single and dual-platform. For the assessment of the single-platform, Procount and SCE kits were used, both of which use fluorescent beads as a counting reference to obtain absolute CD34+ cells numbers. Moreover, after the acquisition of samples in flow cytometer AccuriTM C6, following the protocol established for each kit, the number of CD34+ cells was recalculated, considering the cell count provided by the AccuriTM C6. Main Results In our analysis, the results showed a strong correlation between the number of CD34+ cells/μL (r2 = 0.77) when comparing the SCE kit and the current dual-platform method. On the other hand, the comparison between Procount kit and dual-platform results showed a moderate correlation for the number of CD34+/μL cells (r2 = 0.64). Conclusion Our results showed that the AccuriTM C6 flow cytometer can be used safely, applying both the dual and single platform analysis strategy. Considering the ISHAGE protocol-based single-platform approach, as the most appropriate methodology for CD34+ cells enumeration, our results demonstrated that the SCE kit has great potential for national standardization of UCB samples analysis methodology.
نوع الوثيقة: article
وصف الملف: text/html
اللغة: English
تدمد: 2531-1379
DOI: 10.1016/j.htct.2020.09.151
URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792022000100049
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edssci.S2531.13792022000100049
قاعدة البيانات: SciELO
الوصف
تدمد:25311379
DOI:10.1016/j.htct.2020.09.151